Counterparts Clause Example from Business Contracts

This example Counterparts clause appears in 16 contracts from 14 companies

Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile or electronic transmission.
Found in Pulmatrix, Inc. contract
Pulmatrix, Inc. Contracts

PULMATRIX, INC. UP TO$11,000,000 OF COMMON STOCK (par value $0.0001 per share) AT-THE-MARKET SALES AGREEMENT (Filed With SEC on March 17, 2017)

Onconova Therapeutics, Inc. Contracts

ONCONOVA THERAPEUTICS, INC. Shares of Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement (Filed With SEC on December 5, 2016)

Cyclacel Pharmaceuticals, Inc. Contracts

Cyclacel Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on June 23, 2016)

GLADSTONE COMMERCIAL CORP Contracts

GLADSTONE COMMERCIAL CORPORATION UP TO $40,000,000 OF SHARES SERIES A PREFERRED STOCK SERIES B PREFERRED STOCK CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT (Filed With SEC on February 22, 2016)

GLADSTONE COMMERCIAL CORPORATION UP TO $50,000,000 OF SHARES SERIES D PREFERRED STOCK CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT (Filed With SEC on June 23, 2016)

GLADSTONE COMMERCIAL CORPORATION UP TO $100,000,000 OF SHARES OF COMMON STOCK CONTROLLED EQUITY OFFERINGSM SALES AGREEMENT (Filed With SEC on September 2, 2014)

ENERGY FUELS INC Contracts

Sales Agreement (Filed With SEC on December 23, 2016)

Ampio Pharmaceuticals, Inc. Contracts

AMPIO PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on February 10, 2016)

CATABASIS PHARMACEUTICALS INC Contracts

CATABASIS PHARMACEUTICALS, INC. $10,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on August 11, 2016)

HEAT BIOLOGICS, INC. Contracts

At Market Issuance Sales Agreement, dated August 15, 2016, by and between Heat Biologics, Inc. and FBR Capital Markets & Co (Filed With SEC on August 15, 2016)

ACELRX PHARMACEUTICALS INC Contracts

AcelRx Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on June 21, 2016)

Corbus Pharmaceuticals Holdings, Inc. Contracts

CORBUS PHARMACEUTICALS HOLDINGS, INC. Shares of Common Stock (par value$0.0001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 23, 2016)

Synthetic Biologics, Inc. Contracts

SYNTHETIC BIOLOGICS, INC. Shares of Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement (Filed With SEC on August 5, 2016)

TITAN PHARMACEUTICALS INC Contracts

TITAN PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on September 1, 2016)

TRANSENTERIX INC. Contracts

TransEnterix, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSMSales Agreement (Filed With SEC on February 9, 2016)

Savara Inc Contracts

MAST THERAPEUTICS, INC. $30,000,000 SALESAGREEMENT (Filed With SEC on February 10, 2014)